Results 151 to 160 of about 18,302 (321)

Unraveling Adrenal Oncocytoma: Clinical Presentation, Diagnosis, and Surgical Success. [PDF]

Cureus
N A, Anne D, Shetty B, Velagapudi M, Nadella N.   +4 more
europepmc   +1 more source

Spatial Heterogeneity of PD‐L1 Expression as a Biomarker for Third‐Generation EGFR‐TKI Response in Advanced EGFR‐Mutant NSCLC

Cancer Science, EarlyView.
In advanced EGFR‐mutant NSCLC, high PD‐L1 expression may indicate reduced efficacy of third‐generation EGFR‐TKIs. PD‐L1 expression in primary lesions may serve as a prognostic marker, whereas expression in metastatic lymph nodes does not. This spatial heterogeneity could affect PD‐L1's predictive accuracy for third‐generation EGFR‐TKIs efficacy ...
Yidan Zhang, Yingqi Xu, Hongping Jin, Tengfei Liu, Hua Zhong, Jianlin Xu, Yuqing Lou, Runbo Zhong   +7 more
wiley   +1 more source

A Second Look at Cushing Disease: Hypercortisolism Recurrence From Another Gland. [PDF]

JCEM Case Rep
Martinez-Gil M, Yuen KCJ.
europepmc   +1 more source

Approach to the Management of Gastrointestinal Manifestations in Patients With Phaeochromocytoma and Paraganglioma

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Managing gastrointestinal symptoms in patients with phaeochromocytoma and paraganglioma (PPGL) is challenging due to the risk of catecholaminergic crisis with many commonly prescribed medications, especially in functional tumours.
Monica Majumder, Cherie Chiang, Grace Kong, Michael Michael, Nirupa Sachithanandan, Emma Boehm   +5 more
wiley   +1 more source

Inflammatory myofibroblastic tumor of the adrenal gland: A case report. [PDF]

Int J Surg Case Rep
Sahraoui G, Elfekih S, Sassi I, Charfi L, Mrad K.   +4 more
europepmc   +1 more source

Genetic Testing Referral Rates for Pheochromocytoma and Paraganglioma in an Academic Tertiary Centre

Clinical Endocrinology, EarlyView.
ABSTRACT Background Clinical guidelines recommend genetic counselling for all patients with pheochromocytoma or paraganglioma (PPGL). Barriers to accessing genetics evaluation are incompletely understood. The objective of this study was to identify individual‐ and provider‐level barriers to genetic testing.
Brian Ruhle, Na Eun Kim, Sang Ngo, Elena G. Hughes, Dipti P. Sajed, Run Yu, James X. Wu, Michael W. Yeh, Masha J. Livhits   +8 more
wiley   +1 more source

Adrenal infections update: how radiologists can contribute to patient care. [PDF]

Br J Radiol
Abreu-Gomez J, Murad V, Ezzat S, Navin PJ, Westphalen AC.   +4 more
europepmc   +1 more source

Cytological Assessment of Adrenal Tumours: Insights From 22‐Years Single Centre Experience

Clinical Endocrinology, EarlyView.
ABSTRACT Objective The incidence of adrenal tumours has increased in the last decades, mainly due to increased use of imaging. The diagnostic evaluation of adrenal masses can be complex and, in some cases, necessitates cytological evaluation. However, concerns remain regarding the potential complications associated with adrenal gland biopsy.
Ana Carasel, Jan Calissendorff, C. Christofer Juhlin, Henrik Falhammar   +3 more
wiley   +1 more source

Intraoperative Ultrasound Guidance in Laparoscopic Adrenalectomy: A Retrospective Analysis of Perioperative Outcomes. [PDF]

Diagnostics (Basel)
Mihai I, Boicean A, Dura H, Teodoru CA, Bratu DG, Ichim C, Todor SB, Bacalbasa N, Bereanu AS, Hașegan A.   +9 more
europepmc   +1 more source

Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1

Clinical Endocrinology, EarlyView.
SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley   +1 more source